ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,713Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 682

$1.14M Total Retail Price of All Prescriptions

Rank: 72 out of 682

601 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 601 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 15,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 602 519 1 5
AMLODIPINE BESYLATE 473 433 2 6
LISINOPRIL 473 395 2 2
HYDROCODONE-ACETAMINOPHEN 470 358 S3 4 1
SIMVASTATIN 449 386 5 4
LEVOTHYROXINE SODIUM 440 422 6 3
FUROSEMIDE 439 427 7 7
METOPROLOL SUCCINATE 415 362 8 16
WARFARIN SODIUM 345 341 9 13
ATORVASTATIN CALCIUM 344 321 10 11
METFORMIN HCL 289 263 11 8
GABAPENTIN 269 231 12 9
NEXIUM 245 210 13 19
ZOLPIDEM TARTRATE 217 194 14 21
POTASSIUM CHLORIDE 216 211 15 14
DIGOXIN 200 195 16 46
CITALOPRAM HBR 200 195 16 17
GLIMEPIRIDE 199 183 18 43
LOSARTAN POTASSIUM 192 174 19 20
METOPROLOL TARTRATE 191 180 20 10
NAMENDA 163 163 21 41
PRAVASTATIN SODIUM 162 135 22 15
PANTOPRAZOLE SODIUM 159 150 23 29
PREDNISONE 156 155 24 40
CARVEDILOL 155 147 25 23
TAMSULOSIN HCL 150 150 26 33
ALLOPURINOL 142 128 27 32
CLOPIDOGREL 139 129 28 25
METFORMIN HCL ER 137 133 29 68
CLONIDINE HCL 134 121 30 48
METHYLPREDNISOLONE 132 116 31 127
TRAMADOL HCL 130 104 32 26
DOXAZOSIN MESYLATE 129 129 33 96
CELEBREX 125 118 34 80
SYNTHROID 123 113 35 59
NAPROXEN 123 108 35 97
AMOXICILLIN 123 105 35 113
SULFAMETHOXAZOLE-TRIMETHOPRIM 123 112 35 103
HYDROCHLOROTHIAZIDE 120 105 39 12
ISOSORBIDE MONONITRATE ER 117 113 40 31
AZITHROMYCIN 117 110 40 39
PLAVIX 114 100 42 35
CYMBALTA 112 96 43 51
SPIRONOLACTONE 107 107 44 64
CIPROFLOXACIN HCL 104 101 45 58
TRIAMTERENE-HCTZ 102 97 46 57
DONEPEZIL HCL 102 102 46 30
VITAMIN D2 101 99 48 206
RAMIPRIL 99 86 49 81
BUMETANIDE 96 96 50 115
ROPINIROLE HCL 94 90 51 71
AMITRIPTYLINE HCL 93 82 R 52 50
BUSPIRONE HCL 93 74 52 102
MELOXICAM 92 84 54 27
CRESTOR 75 27 55 22
MECLIZINE HCL 75 75 55 124
KLOR-CON M20 74 71 57 67
DICLOFENAC SODIUM 74 67 57 107
SERTRALINE HCL 72 64 59 24
ACTOS 69 52 60 151
MIRTAZAPINE 69 66 60 52
LOSARTAN-HYDROCHLOROTHIAZIDE 69 58 60 56
ESCITALOPRAM OXALATE 65 51 63 73
PAROXETINE HCL 65 55 63 53
ALPRAZOLAM 65 63 63 90
ALENDRONATE SODIUM 64 58 66 37
ZETIA 64 41 66 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 61 66 34
NABUMETONE 63 60 69 227
SPIRIVA 62 60 70 49
ATENOLOL 61 59 71 18
TOPROL XL 59 59 72 358
BENAZEPRIL HCL 59 59 72 89
KLOR-CON 10 58 58 74 148
IRBESARTAN 58 54 74 234
GLIPIZIDE ER 57 57 76 108
VYTORIN 57 46 76 145
DIOVAN 57 57 76 42
DILTIAZEM 24HR ER 54 54 79 162
ADVAIR DISKUS 54 48 79 47
DILTIAZEM 24HR CD 52 52 81 123
NIASPAN 51 36 82 133
GLIPIZIDE 50 50 83 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.